Daré Bioscience, Inc.

Stocks

DARE

US23666P2002

Market Closed - Nasdaq 08:30:00 07/11/26 am AEDT			5-day change	1st Jan Change
0.6390 ^USD	+2.40%		-8.66%	-66.89%

26/10	Daré Bioscience, Inc. Showcases Its Investigational Programmable Device, DARE-IDDS, At PODD	CI
09/10	Daré Bioscience, Inc. Presents Phase 1 Sildenafil Cream Data At Sexual Medicine Society of North America Annual Fall Scientific Meeting	CI

Transcript : Daré Bioscience, Inc. - Special Call

Published on 08/27/2026 at 06:35 am AEST - Modified on 10/10/2026 at 06:50 am AEDT

S&P Capital IQ

Presenter Speech
Jenene Thomas (Attendees)

Okay. We are ready to get started. Welcome, and thank you for joining the Dare Bioscience Virtual Bus Tour. My name is Jenene Thomas. I am CEO of JTC IR, and

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Daré Bioscience, Inc.

26/10	Daré Bioscience, Inc. Showcases Its Investigational Programmable Device, DARE-IDDS, At PODD	CI
09/10	Daré Bioscience, Inc. Presents Phase 1 Sildenafil Cream Data At Sexual Medicine Society of North America Annual Fall Scientific Meeting	CI
29/09	Daré Bioscience, Inc. Announces Dare-Hpv Phase 2 Study for Persistent High-Risk Hpv Infection Underway	CI
14/09	Daré Bioscience Publishes Phase 1 Clinical Study Results for Topical Sildenafil Cream 3.6%	CI
01/09	Daré Bioscience Receives New NIH Funding Award Of Approximately USD 908,000 To Advance DARE-PTB2 For The Prevention Of Preterm Birth	CI
27/08	Daré Bioscience, Inc. - Special Call
15/08	Dare Bioscience Prices $6 Million Registered Direct Offering; Shares Fall	MT
14/08	Daré Bioscience, Inc., Q2 2026 Earnings Call, Aug 13, 2026
14/08	Daré Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
12/08	Daré Bioscience, Inc. - Special Call
06/08	Daré Bioscience, Inc. - Special Call
28/07	Daré Bioscience, Inc. Expands Access Options For DARE To PLAY And Specialized Menopause Care Through Strategic Collaboration With MyMenopauseRx	CI
24/07	Daré Bioscience, Inc. - Special Call
01/07	Daré Bioscience Announces Flora Sync LF5 Is Now Available And Provides Updates On Product Pipeline	CI
29/06	Daré Bioscience, Inc.(NasdaqCM:DARE) added to Russell 3000E Growth Benchmark	CI